134 related articles for article (PubMed ID: 10524408)
21. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion.
Taussky D; Austen L; Toi A; Yeung I; Williams T; Pearson S; McLean M; Pond G; Crook J
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):974-80. PubMed ID: 15989997
[TBL] [Abstract][Full Text] [Related]
22. Potential role of various dosimetric quality indicators in prostate brachytherapy.
Merrick GS; Butler WM; Dorsey AT; Lief JH
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):717-24. PubMed ID: 10348304
[TBL] [Abstract][Full Text] [Related]
23. Difference in rectal dosimetry between pre-plan and post-implant analysis in transperineal interstitial brachytherapy for prostate cancer.
Ishiyama H; Kitano M; Satoh T; Niibe Y; Uemae M; Fujita T; Baba S; Hayakawa K
Radiother Oncol; 2006 Feb; 78(2):194-8. PubMed ID: 16414135
[TBL] [Abstract][Full Text] [Related]
24. Seed displacements after permanent brachytherapy for prostate cancer in dependence on the prostate level.
Pinkawa M; Gagel B; Asadpour B; Piroth MD; Klotz J; Borchers H; Jakse G; Eble MJ
Strahlenther Onkol; 2008 Oct; 184(10):520-5. PubMed ID: 19016041
[TBL] [Abstract][Full Text] [Related]
25. Can the Day 0 CT-scan predict the post-implant scanning? Results from 136 prostate cancer patients.
Cattani F; Vavassori A; Comi S; Gherardi F; Russo S; Orecchia R; Jereczek-Fossa BA
Phys Med; 2017 Aug; 40():66-71. PubMed ID: 28743617
[TBL] [Abstract][Full Text] [Related]
26. Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy.
Merrick GS; Butler WM; Dorsey AT; Walbert HL
Radiat Oncol Investig; 1998; 6(4):182-90. PubMed ID: 9727878
[TBL] [Abstract][Full Text] [Related]
27. Influence of prostate volume on dosimetry results in real-time 125I seed implantation.
McNeely LK; Stone NN; Presser J; Chircus JH; Stock RG
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):292-9. PubMed ID: 14697451
[TBL] [Abstract][Full Text] [Related]
28. Timing of postseed imaging influences rectal dose-volume parameters for cesium-131 prostate seed implants.
Yaparpalvi R; Hannan R; Landau E; Kahan N; Bodner W; Kuo HC; Minsky L; Mehta KJ; Garg MK; Kalnicki S; Guha C
Brachytherapy; 2012; 11(6):489-94. PubMed ID: 21868289
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric quality and evolution of edema after low-dose-rate brachytherapy for small prostates: implications for the use of newer isotopes.
Kovtun KA; Wolfsberger L; Niedermayr T; Sugar EN; Graham PL; Murciano-Goroff Y; Beard C; D'Amico AV; Martin NE; Orio PF; Nguyen PL
Brachytherapy; 2014; 13(2):152-6. PubMed ID: 23911279
[TBL] [Abstract][Full Text] [Related]
30. Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy.
Nasser NJ; Cohen GN; Dauer LT; Zelefsky MJ
Brachytherapy; 2016; 15(4):420-425. PubMed ID: 27180125
[TBL] [Abstract][Full Text] [Related]
31. Biologically effective dose for permanent prostate brachytherapy taking into account postimplant edema.
Van Gellekom MP; Moerland MA; Kal HB; Battermann JJ
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):422-33. PubMed ID: 12023147
[TBL] [Abstract][Full Text] [Related]
32. Effect of edema associated with 131Cs prostate permanent seed implants on dosimetric quality indices.
Kehwar TS; Jones HA; Huq MS; Beriwal S; Benoit RM; Smith RP
Med Phys; 2009 Aug; 36(8):3536-42. PubMed ID: 19746787
[TBL] [Abstract][Full Text] [Related]
33. Effect of edema on postimplant dosimetry in prostate brachytherapy using CT/MRI fusion.
Tanaka O; Hayashi S; Matsuo M; Nakano M; Uno H; Ohtakara K; Miyoshi T; Deguchi T; Hoshi H
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):614-8. PubMed ID: 17869675
[TBL] [Abstract][Full Text] [Related]
34. Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis.
Snyder KM; Stock RG; Hong SM; Lo YC; Stone NN
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):335-41. PubMed ID: 11380219
[TBL] [Abstract][Full Text] [Related]
35. Narrow safety range of intraoperative rectal irradiation exposure volume for avoiding bleeding after seed implant brachytherapy.
Nakamura R; Kikuchi K; Tanji S; Yabuuchi T; Uwano I; Yamaguchi S; Ariga H; Fujioka T
Radiat Oncol; 2012 Jan; 7():15. PubMed ID: 22293400
[TBL] [Abstract][Full Text] [Related]
36. Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations.
Li XA; Wang JZ; Stewart RD; DiBiase SJ
Phys Med Biol; 2003 Sep; 48(17):2753-65. PubMed ID: 14516099
[TBL] [Abstract][Full Text] [Related]
37. Postimplant rectal dosimetry is not dependent on 103Pd or 125I seed activity.
Merrick GS; Sylvester J; Grimm P; Allen ZA; Butler WM; Reed JL; Khanjian J
Brachytherapy; 2011; 10(1):35-43. PubMed ID: 20153264
[TBL] [Abstract][Full Text] [Related]
38. Potential impact of prostate edema on the dosimetry of permanent seed implants using the new 131Cs (model CS-1) seeds.
Chen Z; Deng J; Roberts K; Nath R
Med Phys; 2006 Apr; 33(4):968-75. PubMed ID: 16696473
[TBL] [Abstract][Full Text] [Related]
39. Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy.
Wang JZ; Mayr NA; Nag S; Montebello J; Gupta N; Samsami N; Kanellitsas C
Med Phys; 2006 Apr; 33(4):1025-32. PubMed ID: 16696479
[TBL] [Abstract][Full Text] [Related]
40. Isotope selection for patients undergoing prostate brachytherapy.
Cha CM; Potters L; Ashley R; Freeman K; Wang XH; Waldbaum R; Leibel S
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):391-5. PubMed ID: 10487561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
